gadofosveset trisodium has been researched along with Cardiovascular Stroke in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botnar, RM; Dong, X; Lavin, B; Lorrio, S; Phinikaridou, A; Protti, A; Shah, A | 1 |
Fleck, E; Kelle, S; Kokocinski, T; Nagel, E; Schnackenburg, B; Thouet, T | 1 |
1 trial(s) available for gadofosveset trisodium and Cardiovascular Stroke
Article | Year |
---|---|
Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Infarction; Organometallic Compounds | 2012 |
1 other study(ies) available for gadofosveset trisodium and Cardiovascular Stroke
Article | Year |
---|---|
MRI with gadofosveset: A potential marker for permeability in myocardial infarction.
Topics: Animals; Capillary Permeability; Contrast Media; Coronary Vessels; Disease Models, Animal; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging, Cine; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2018 |